Skip to main content
Skip to main content
KWBT logo

Kiwa Bio-Tech Products Group Corporation (KWBT)

$0.00 +$0.00 (+0.00%) |CouncilBUY · 55 · B
Bottom line: BUY — our Council read (55/100) and AI Score (51/100) broadly agree. Strongest signal: Seth Klarman bullish · Biggest watch-out: Jim Simons bearish.
MCap: 56K| Vol: 11.0K|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Kiwa Bio-Tech Products Group Corporation (KWBT) trades at $0.00 with AI Score 51/100 (Grade B). Kiwa Bio-Tech Products Group Corporation develops, manufactures, and distributes bio-technological products for the agricultural market, primarily in China. Market cap: $56,477, Sector: Basic materials.

Price live · AI analysis from Mar 17, 2026
Kiwa Bio-Tech Products Group Corporation develops, manufactures, and distributes bio-technological products for the agricultural market, primarily in China. The company focuses on bio-fertilizers to improve crop yields and soil health.

Analyst Coverage for KWBT: KWBT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates KWBT against Basic Materials peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
BUY 55/100 · B

KWBT: 3/7 perspectives are bullish. Dominant signal: Seth Klarman bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Ken Griffin
Bullish
Jim Simons
Bearish
Izzy Englander
Neutral
Seth Klarman
Bullish
Moon AI
Neutral
Council Score · 8 perspectives · See tabs for details →

Kiwa Bio-Tech Products Group Corporation (KWBT) Materials & Commodity Exposure

CEOZiqi Wang
Employees16
HeadquartersYangling, CN
IPO Year2002

Kiwa Bio-Tech Products Group Corporation focuses on developing and distributing bio-fertilizers in the Chinese agricultural market, leveraging strategic partnerships and proprietary technology to offer sustainable solutions for crop yield enhancement and soil health, operating within a competitive landscape of both domestic and international players.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 17, 2026

What Is the Investment Thesis for KWBT?

Kiwa Bio-Tech Products Group Corporation presents a focused play on the growing demand for bio-fertilizers in China. The company's strategic partnerships with research institutions and its range of bio-fertilizer products position it to capitalize on the increasing adoption of sustainable agricultural practices. However, the company's negative profit margin of -16.6% and lack of dividend payments raise concerns about its financial stability. The high beta of 2.91 suggests significant volatility. Future growth hinges on successful product commercialization, expansion of distribution networks, and effective management of operational costs. Investors should closely monitor the company's ability to achieve profitability and generate positive cash flow.

Based on FMP financials and quantitative analysis

KWBT Key Highlights

  • Kiwa Bio-Tech operates in the agricultural inputs sector, focusing on bio-fertilizers.
  • The company's products include bacillus species-based biological organic, compound microbial, bio-water soluble, and microbial inoculum fertilizers.
  • Kiwa Bio-Tech has strategic cooperation agreements with several agricultural research institutions in China.
  • The company's gross margin is 23.3%.
  • The company's profit margin is -16.6%.

Who Are KWBT's Competitors?

KWBT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
MBII Marrone Bio Innovations, Inc. $0.80 -20.19% 68
AGRZ Agroz Inc. $0.39 -2.16% $8.45M 61
KNGW Kenongwo Group US, Inc. $0.32 +0.00% $32.60M 59
BHST BioHarvest Sciences Inc. $3.00 +4.53% $51.98M 59
ITFS Itafos Inc. $1.75 -2.23% $340.87M 52
YARIY Yara International ASA $21.98 -0.09% $22.40B 52
YRAIF Yara International ASA $49.65 +4.42% $12.65B 52
CF CF Industries Holdings, Inc. $114.05 +3.17% $17.52B 52

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are KWBT's Key Strengths?

  • Proprietary bio-fertilizer technology
  • Strategic partnerships with research institutions
  • Established presence in the Chinese market
  • Focus on sustainable agriculture

What Are KWBT's Weaknesses?

  • Negative profit margin
  • Limited financial resources
  • Dependence on the Chinese market
  • Small number of employees

What Could Drive KWBT Stock Higher?

  • Increasing demand for bio-fertilizers in China due to environmental concerns and government support.
  • Strategic partnerships with research institutions to develop innovative products.
  • Potential expansion into new geographic markets within China.
  • Development and launch of new bio-fertilizer products targeting specific crops.
  • Government subsidies and incentives for sustainable agriculture practices.

What Are the Key Risks for KWBT?

  • Financial-distress signal — its Altman Z-Score of 1.21 sits in the distress zone (elevated bankruptcy risk).
  • Negative return on equity (-59.2%) — the business is not currently generating profit on shareholder capital.
  • Competition from larger agricultural companies with greater resources.
  • Fluctuations in raw material prices affecting production costs.
  • Changes in government regulations impacting the bio-fertilizer industry.
  • Economic slowdown in China reducing demand for agricultural products.
  • Limited financial resources and negative profit margin.

What Are the Growth Opportunities for KWBT?

  • Expansion of Product Line: Kiwa Bio-Tech can expand its product line to include a wider range of bio-fertilizers and related agricultural products. This could involve developing new formulations, targeting specific crops, or addressing specific soil conditions. The market for specialized bio-fertilizers is growing, as farmers seek tailored solutions for their needs. This expansion could increase revenue streams and market share, with a potential market size of $5 billion by 2030.
  • Geographic Expansion within China: Kiwa Bio-Tech can expand its geographic reach within China, targeting regions with high agricultural activity and a growing demand for bio-fertilizers. This could involve establishing new distribution partnerships, opening regional offices, or participating in agricultural trade shows. The Chinese agricultural market is vast and diverse, offering significant opportunities for growth. This expansion could increase sales volume and brand awareness, with a timeline of 3-5 years.
  • Strategic Partnerships and Acquisitions: Kiwa Bio-Tech can pursue strategic partnerships and acquisitions to enhance its technological capabilities, expand its product portfolio, or gain access to new markets. This could involve collaborating with research institutions, acquiring smaller bio-fertilizer companies, or partnering with agricultural distributors. Strategic alliances can accelerate growth and create synergies, with ongoing opportunities.
  • Increased Focus on Research and Development: Kiwa Bio-Tech can increase its investment in research and development to develop innovative bio-fertilizer products and improve existing formulations. This could involve conducting field trials, collaborating with universities, or hiring experienced scientists. Innovation is crucial for maintaining a competitive edge in the bio-fertilizer market, with a continuous timeline.
  • Government Support and Subsidies: Kiwa Bio-Tech can leverage government support and subsidies for the development and adoption of bio-fertilizers. The Chinese government is actively promoting sustainable agriculture and providing financial incentives for farmers to use environmentally friendly products. This support can reduce costs and increase demand for Kiwa Bio-Tech's products, with ongoing opportunities.

What Opportunities Does KWBT Have?

  • Expanding product line
  • Geographic expansion within China
  • Increasing demand for bio-fertilizers
  • Government support for sustainable agriculture

What Threats Does KWBT Face?

  • Competition from larger agricultural companies
  • Fluctuations in raw material prices
  • Changes in government regulations
  • Economic slowdown in China

What Are KWBT's Competitive Advantages?

  • Proprietary bio-fertilizer formulations
  • Strategic partnerships with research institutions
  • Established distribution network in China
  • Brand recognition in the Chinese agricultural market

What Does KWBT Do?

Kiwa Bio-Tech Products Group Corporation, established in 2002 and headquartered in Yangling, China, is dedicated to the development, manufacturing, and distribution of bio-technological products tailored for the agricultural sector. The company's core offerings include a range of bio-fertilizers, encompassing bacillus species-based biological organic fertilizers, compound microbial fertilizers, bio-water soluble fertilizers, and microbial inoculum fertilizers. These products are designed to enhance crop yields, improve soil health, and promote sustainable agricultural practices. Kiwa Bio-Tech has strategically aligned itself with key institutions such as the Beijing Zhongpin Agricultural Science and Technology Development Center, the China Academy of Agricultural Science's Institute of Agricultural Resources & Regional Planning, and the Institute of Agricultural Economy & Development, as well as Kiwa Bio-Tech (Yangling) Co. Ltd. These collaborations facilitate research, development, and market access within the Chinese agricultural landscape. The company's focus on bio-fertilizers addresses the growing demand for environmentally friendly agricultural solutions in China, driven by increasing awareness of soil degradation and the need for sustainable farming practices.

What Products and Services Does KWBT Offer?

  • Develops bio-technological products for the agricultural market.
  • Manufactures bio-fertilizers.
  • Markets bio-fertilizers.
  • Distributes bio-fertilizers.
  • Offers bacillus species-based biological organic fertilizers.
  • Offers compound microbial fertilizers.
  • Offers bio-water soluble fertilizers.
  • Offers microbial inoculum fertilizers.

How Does KWBT Make Money?

  • Develops and manufactures bio-fertilizers.
  • Sells bio-fertilizers to distributors and farmers.
  • Generates revenue through product sales.
  • Forms strategic partnerships for research and development.

What Industry Does KWBT Operate In?

Kiwa Bio-Tech operates within the agricultural inputs industry, specifically focusing on the bio-fertilizer segment. The Chinese agricultural sector is undergoing a shift towards sustainable practices, driven by government regulations and increasing awareness of environmental concerns. The market for bio-fertilizers is growing, as farmers seek alternatives to traditional chemical fertilizers. Kiwa Bio-Tech competes with both domestic and international players in this space. The industry is characterized by technological innovation, product differentiation, and the need for strong distribution networks to reach farmers across China.

Who Are KWBT's Key Customers?

  • Farmers in China
  • Agricultural distributors
  • Agricultural cooperatives
  • Large-scale agricultural operations
AI Confidence: 69% Updated: Mar 17, 2026

Company Profile

Kiwa Bio-Tech Products Group Corporation operates in the Agricultural Inputs industry within the Basic Materials sector. It is headquartered in Yangling, CN. The company is led by CEO Ziqi Wang. KWBT has traded publicly since 2002.

How Kiwa Bio-Tech Products Group Corporation Is Valued

Kiwa Bio-Tech Products Group Corporation carries a market capitalization of 56K, placing it in the micro-cap category. Relative to its peer group, KWBT's quantitative score of 51/100 is roughly in line with the peer average of 60/100.

ROE -59%Key Financial Metrics

Return on equity for Kiwa Bio-Tech Products Group Corporation stands at -59.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -27.6%, showing how much profit it generates from its asset base. A current ratio of 1.60 indicates the company holds enough short-term assets to cover its near-term obligations.

F-Score 4/9Financial Health

Kiwa Bio-Tech Products Group Corporation's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.21 places it in the distress zone, a signal of elevated financial risk.

KWBT Financials

Fundamental Snapshot

Return on Equity (TTM)
-59.2%
Current Ratio
1.6

Based on FMP financials and quantitative analysis

Bull Case vs Bear Case

Bull Case

  • Proprietary bio-fertilizer technology
  • Strategic partnerships with research institutions
  • Established presence in the Chinese market
  • Focus on sustainable agriculture

Bear Case

  • Negative profit margin
  • Limited financial resources
  • Dependence on the Chinese market
  • Small number of employees

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

KWBT Latest News

No recent news available for KWBT.

KWBT Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for KWBT.

Price Targets

Wall Street price target analysis for KWBT.

KWBT MoonshotScore

51/100

What does this score mean?

The MoonshotScore rates KWBT's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Ziqi Wang

CEO

Ziqi Wang serves as the CEO of Kiwa Bio-Tech Products Group Corporation. Information regarding Ziqi Wang's detailed career history, education, and previous roles is not available in the provided data. Further research would be needed to provide a comprehensive background.

Track Record: Due to limited information, Ziqi Wang's key achievements, strategic decisions, and company milestones under their leadership cannot be accurately assessed. Additional data is required to evaluate their track record effectively.

KWBT OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Kiwa Bio-Tech Products Group Corporation may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited regulatory oversight and potentially higher risks compared to companies listed on major exchanges or higher OTC tiers. This tier often includes companies with distressed financials, early-stage ventures, or those that choose not to comply with stricter listing standards.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Trading volume for OTC Other stocks like KWBT is typically very low, resulting in wide bid-ask spreads. This can make it difficult to buy or sell shares without significantly impacting the price. Investors may experience challenges in executing large trades or exiting their positions quickly due to the limited liquidity.
OTC Risk Factors:
  • Limited financial disclosure
  • Low trading volume and liquidity
  • Potential for price manipulation
  • Higher risk of fraud or mismanagement
  • Lack of regulatory oversight
Due Diligence Checklist:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's legal and regulatory compliance.
  • Check for any red flags or warning signs.
  • Consult with a financial advisor.
  • Understand the risks associated with investing in OTC stocks.
Legitimacy Signals:
  • Strategic partnerships with reputable organizations
  • Positive media coverage or industry recognition
  • Experienced management team
  • Clear business plan and growth strategy
  • Audited financial statements (if available)

Common Questions About KWBT (Basic Materials)

What does Kiwa Bio-Tech Products Group Corporation do?

Kiwa Bio-Tech Products Group Corporation develops, manufactures, and distributes a range of bio-fertilizers for the agricultural market, primarily in China. These bio-fertilizers are designed to enhance crop yields, improve soil health, and promote sustainable agricultural practices. The company leverages strategic partnerships with research institutions to develop and commercialize its products, targeting the growing demand for environmentally friendly agricultural solutions.

What do analysts say about KWBT stock?

As of 2026-03-17, there is no available analyst coverage or consensus on Kiwa Bio-Tech Products Group Corporation (KWBT). The company's market capitalization is $0.00B, and it trades on the OTC market. Investors should conduct their own due diligence and consider the risks associated with investing in OTC stocks, including limited liquidity and financial disclosure.

What are the main risks for KWBT?

Kiwa Bio-Tech Products Group Corporation faces several risks, including competition from larger agricultural companies, fluctuations in raw material prices, and changes in government regulations. The company's negative profit margin and limited financial resources also pose significant challenges. Additionally, as an OTC-listed company, KWBT is subject to higher risks associated with limited liquidity, financial disclosure, and regulatory oversight.

What are the key factors to evaluate for KWBT?

Kiwa Bio-Tech Products Group Corporation (KWBT) holds an AI score of 51/100 (moderate). Not financial advice.

How frequently does KWBT data refresh on this page?

KWBT prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven KWBT's recent stock price performance?

Kiwa Bio-Tech Products Group Corporation (KWBT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary bio-fertilizer technology. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider KWBT overvalued or undervalued right now?

Valuing Kiwa Bio-Tech Products Group Corporation (KWBT) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying KWBT?

Before investing in Kiwa Bio-Tech Products Group Corporation (KWBT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited information available on the company's financials and operations.
  • OTC market carries inherent risks due to lower regulation and liquidity.
Data Sources

Popular Stocks